Condition
T-lymphoblastic Lymphoma clinical trials and research
As of November 12, 2026, Find a Trial lists 5 T-lymphoblastic Lymphoma clinical trials that are recruiting, at sites in 2 countries (most in China (4), United States (1)). By phase: Phase 1/2 (2), Phase 2 (1), Phase 1 (1), Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 2Countries
Newest T-lymphoblastic Lymphoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Adaptive dual-target CAR-T therapy for relapsed or refractory blood cancers | Phase 1/2 | Shenzhen, Guangdong | Recruiting | Apr 13, 2026 |
| Using CD5 CAR-T Cells to treat relapsed T-lymphoma | Early Phase 1 | Hangzhou, Zhejiang | Recruiting | Oct 9, 2024 |
| Combination treatment for advanced NK/T-cell lymphoma | Phase 1/2 | Beijing, Beijing Municipality | Recruiting | Apr 19, 2024 |
| CAR-T therapy for adults with relapsed or refractory T-lymphoblastic lymphoma or leukemia | Phase 1 | Shanghai | Recruiting | Nov 18, 2023 |
| Combination chemotherapy and nelarabine for T-cell leukemia and lymphoma | Phase 2 | Houston, Texas | Recruiting | Jul 16, 2007 |
All recruiting trials (5)
-
Adaptive dual-target CAR-T therapy for relapsed or refractory blood cancers
This trial will test whether matching a patient's cancer markers to one of several dual-target CAR-T therapies can work and be safe for adults whose blood cancer has come back or not responded.
-
Using CD5 CAR-T Cells to treat relapsed T-lymphoma
This study is testing a new type of CAR-T cell therapy to see if it can help people with relapsed T-lymphoma feel better and improve their health.
-
Combination treatment for advanced NK/T-cell lymphoma
This study is testing a new combination treatment for people with advanced NK/T-cell lymphoma to see if it is safe and effective.
-
CAR-T therapy for adults with relapsed or refractory T-lymphoblastic lymphoma or leukemia
This study is testing a new CAR-T therapy called SENL101 to see if it can help adults with hard-to-treat T-lymphoblastic lymphoma or leukemia feel better and improve their health.
-
Combination chemotherapy and nelarabine for T-cell leukemia and lymphoma
This study is testing a new combination of chemotherapy drugs and nelarabine to see if it helps people with T-cell leukemia and lymphoma feel better and live longer.
Related topics
Quick answers
How many T-lymphoblastic Lymphoma clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (4 trials), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 2, Phase 2: 1, Phase 1: 1, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.